A carregar...

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain

BACKGROUND: Tapentadol prolonged release (PR; 100–250 mg twice daily) has been efficacious and well tolerated for managing moderate-to-severe, chronic osteoarthritis hip or knee pain in phase 3 studies with washout of previous analgesic treatment. OBJECTIVE: The objective of this study was to evalua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Steigerwald, Ilona, Schenk, Michael, Lahne, Uwe, Gebuhr, Peter, Falke, Dietmar, Hoggart, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751342/
https://ncbi.nlm.nih.gov/pubmed/23912473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0102-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!